Business Context and Reporting Period
Company: Bridgeline Digital, Inc. (BLIN)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended September 30, 2025
Business Overview: Bridgeline is an AI-powered marketing technology company offering a suite of products to drive online revenue through site search, personalization, and digital experience platforms. Key products include HawkSearch, Celebros Search, Woorank, Unbound, TruPresence, and OrchestraCMS. The company operates as a single segment (Software) and serves over 2,000 active customers, primarily in North America.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2025 | Fiscal 2024 |
|---|---|---|
| Total Net Revenue | $15,383 | $15,358 |
| Gross Profit | $10,241 | $10,434 |
| Gross Margin | 67% | 68% |
| Operating Loss | $(2,427) | $(2,019) |
| Net Loss | $(2,518) | $(1,961) |
| Net Loss Attributable to Common Shareholders | $(2,849) | $(1,961) |
| Adjusted EBITDA | $(931) | $(192) |
| Cash and Cash Equivalents (End of Period) | $1,626 | $1,390 |
| Total Debt (Current + Long-term) | $326 | $526 |
| Accumulated Deficit | $(94,056) | $(91,538) |
Material Changes vs. Prior Period
- Revenue: Total revenue remained flat at approximately $15.4 million. Subscription revenue increased 2% to $12.4 million, while Services revenue decreased 6% to $3.0 million. Core products (led by HawkSearch) grew 16% to $8.9 million, offsetting declines in legacy products.
- Profitability: Operating loss widened by 20% to $2.4 million, and net loss increased 28% to $2.5 million. The increase in net loss was partially driven by a $0.3 million redemption of Series C Convertible Preferred Stock.
- Expenses: Sales and marketing expenses rose 20% to $4.5 million due to higher marketing spend. Research and development expenses decreased slightly to $4.0 million. Depreciation and amortization dropped 28% as certain intangible assets became fully amortized.
- Liquidity: Cash used in operating activities increased to $1.1 million from $0.8 million. However, financing activities provided $1.4 million in cash, primarily from equity issuances, resulting in a net increase in cash balances.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects to maintain tight control over discretionary spending for fiscal 2026. The company believes future revenues and cash flows will supplement working capital but notes it may require additional financing to execute its business plan.
- Capital Raising: In March 2025, the company completed a registered direct offering and a private placement, raising approximately $2.0 million in gross proceeds. A shelf registration statement allows for up to $50 million in future debt or equity offerings.
- Risks:
- Profitability: The company has a history of net losses and an accumulated deficit of $94 million; there is no assurance it will achieve or sustain profitability.
- Liquidity: Continued losses may necessitate additional financing, which may not be available on acceptable terms.
- Competition: The market is highly competitive with low barriers to entry; competitors include Algolia, Bloomreach, and Coveo.
- AI Integration: While investing heavily in AI (Agentic AI, GenAI), there are risks regarding the cost, complexity, and regulatory environment of these technologies.
- Stock Price: The stock price fluctuated between $1.05 and $2.80 in fiscal 2025. The company must maintain a minimum closing bid price of $1.00 to remain listed on Nasdaq.
- Unusual Items: The net loss included a $0.3 million charge for the redemption of Series C Preferred Stock. Additionally, the company recognized a $4 thousand loss on the change in fair value of warrant liabilities.
Investor Verification Checklist
- Capital Adequacy: Verify the sufficiency of the $1.6 million cash balance against the $1.1 million annual operating cash burn and upcoming debt obligations ($0.2 million due within 12 months).
- Revenue Concentration: Confirm that no single customer exceeds 10% of total revenue (as stated in the filing) and assess the stability of the top 2,000 customers.
- AI Product Adoption: Evaluate the commercial traction of new AI features (Agentic AI, GenAI) to determine if they will drive future subscription growth.
- Dilution Risk: Review the impact of outstanding options (approx. 2.0 million) and warrants (approx. 0.9 million) on future share count and earnings per share.
- Nasdaq Compliance: Monitor the stock price to ensure it remains above the $1.00 minimum bid price requirement to avoid delisting notices.